← Back to Search

Procedure

Gastric Bypass + Kidney Transplant for Obesity and Kidney Failure

N/A
Waitlist Available
Led By Seth Karp, MD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age less than 60 years
Be between 18 and 65 years old
Must not have
Prior weight loss surgery
Prior anti-reflux surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial found that for patients with severe obesity and renal failure, gastric bypass followed by renal transplantation was superior to medical management followed by renal transplant.

Who is the study for?
This trial is for individuals under 60 years old with severe obesity and kidney failure, who have a BMI between 40-55 kg/m2, proper insurance, support person availability, and meet all other criteria for kidney transplant. Excluded are those with HIV, significant lung or heart disease, certain psychiatric conditions like schizophrenia or bipolar disorder, Crohn's disease, past surgeries that conflict with the trial procedures or inability to walk short distances.
What is being tested?
The study is testing if having gastric bypass surgery followed by a kidney transplant provides better outcomes than just medical management before a kidney transplant in patients with severe obesity and renal failure.
What are the potential side effects?
Potential side effects may include typical risks associated with gastric bypass such as nutritional deficiencies, surgical complications like infections or bleeding. Kidney transplantation can also lead to rejection of the organ and infection due to immunosuppressive medications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am younger than 60 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had weight loss surgery in the past.
Select...
I have had surgery to prevent acid reflux.
Select...
I cannot walk 200 feet on my own.
Select...
My lung function is reduced or I need oxygen support.
Select...
I have had a kidney transplant.
Select...
I am a Jehovah's Witness.
Select...
I have serious heart artery problems.
Select...
I am HIV positive.
Select...
I have cirrhosis.
Select...
I do not speak English.
Select...
I have had a hernia repair using mesh before.
Select...
I have been diagnosed with schizophrenia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Ability to reach medical suitability for renal transplant within 18 months after initiating treatment and the change and trajectory of health-related quality of life (HRQOL)
Secondary study objectives
All-cause mortality
Development or regression of diabetes
Development or regression of other comorbidities
+5 more
Other study objectives
Prograf dosing

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Surgical Gastric BypassExperimental Treatment1 Intervention
Patients will undergo surgical gastric bypass according to standard institutional protocols
Group II: Medical Weight Loss ManagementExperimental Treatment1 Intervention
Patients will receive best practices medical management for weight loss under current institutional protocols
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gastric Bypass
2012
Completed Phase 3
~1810

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
902 Previous Clinical Trials
938,757 Total Patients Enrolled
Seth Karp, MDPrincipal Investigator - Vanderbilt University Medical Center
Vanderbilt University Hospital, Vanderbilt University Medical Center
Harvard Medical Sch (Medical School)
Brigham & Women'S Hospital (Residency)

Media Library

Gastric Bypass (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT02128802 — N/A
Kidney Failure Research Study Groups: Medical Weight Loss Management, Surgical Gastric Bypass
Kidney Failure Clinical Trial 2023: Gastric Bypass Highlights & Side Effects. Trial Name: NCT02128802 — N/A
Gastric Bypass (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02128802 — N/A
~6 spots leftby Dec 2025